Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin

Table 3 Severe liver-related events and deaths occurring from the beginning of first treatment according to final virological response

	SVR n = 37	Non SVR n = 76	P
Number of patients with at least one liver-related events or death during follow-up (%)	31 (8.1%)	342 (44.7%)	0.002
Number of patients (%) with
HCC	1 (2.7%)	24 (31.6%)	0.01
Ascites	2 (5.4%)	8 (10.5%)	0.43
Digestive haemorrhage	1 (2.7%)	4 (5.3%)	0.62
Encephalopathy	0	2 (5.4%)	0.56
Number of deaths	0	20 (26.3%)	0.002
Liver-related	0	17
Liver failure	0	7
GI haemorrhage	0	1
HCC	0	9
Non liver-related	0	3
Suicide	0	1
Miscellaneous	0	2

¹1 patient had 2 complications;

²4 patients had 2 complications. SVR: Sustained virological response; GI: Gastrointestinal.